Tibbling Technologies: Redmond AI Profile — Product, Footprint & Verified Record

Modern Seattle computational biology and life-sciences research laboratory overlooking Pacific Northwest evergreens

About Will

I run Tygart Media, an AI-first agency that gets businesses cited and recommended by AI assistants — and I write about what we do, including what breaks.

Connect on LinkedIn →
Washington AI Companies Census · Verified Record (November 19, 2026)
Sourced Baseline: As of November 19, 2026, Tibbling Technologies operates an active research and company website at tibbtech.com detailing its multimodal NeuroAI platform, peer-reviewed publications, and NIH SBIR grant work. The company completed Plug and Play Seattle's third accelerator cohort in mid-2026 and has not publicly disclosed an institutional venture round or acquisition.
PROFILE BRIEF · HOUSE PDF & MARKDOWN TWIN
Tibbling Technologies — Redmond AI Profile
Download the formatted 2-page profile brief (PDF) or open the single-source Markdown twin for Tibbling Technologies. Every claim below links to its verified primary source.

What Tibbling Technologies Builds

Tibbling Technologies is a research-driven NeuroAI and scientific discovery company building biologically grounded multimodal AI systems for neuroscience, spatial biology, medical imaging, and health tech. In GeekWire's March 23, 2026 announcement of Plug and Play Seattle's third cohort, the accelerator described Tibbling Technologies as focused on advanced multimodal AI systems solving complex problems in health tech and neuroscience.

On its official website, Tibbling Technologies presents a research-first portfolio spanning brain-inspired neural architectures, biomedical imaging tools, and clinical health applications. Its work includes neocortex-inspired computational primitives mapped to neuromorphic hardware to improve vision transformer compute efficiency—published in a peer-reviewed paper in the Proceedings of the National Academy of Sciences (PNAS)—as well as an NIH SBIR-funded AI platform for real-time assessment of drug disorders.

  • Drug-disorder assessment platform: Backed by a $400,000 non-dilutive NIH SBIR grant announced in August 2026 to develop an AI system for real-time assessment of drug disorders.
  • Neuroscience and therapeutic discovery tools: Includes AAV enhancer discovery for targeted neuronal therapeutics, automated brain-wide neuron segmentation (Segment AnyNeuron), domain-agnostic 3D brain registration across species and modalities (NeuReg on arXiv), and brainstem-targeting motor circuit discovery.
  • Biologically grounded architectures and applied health models: Covers neuromorphic multimodal sensing for compute-efficient transformers, personalized sports and rehabilitation diagnostics (ExerAIde), behavioral analysis (AnimalFormer), and technical assurance frameworks for brain-inspired computation (Regulating NeuroAI).
Tibbling Technologies — Verified Washington AI Snapshot
Verified profile snapshot for Tibbling Technologies (Redmond, WA) as of November 19, 2026.
FieldVerified Record (As of Nov 19, 2026)
CompanyTibbling Technologies
Official Websitehttps://tibbtech.com/
Washington HQRedmond, WA (federal NIH SBIR grant records); listed as Seattle, WA in Plug and Play Seattle Batch 3
Other WA FootprintPlug and Play Seattle at UW CoMotion Labs (Seattle, WA) and SNBL Global Gateway (Everett, WA); Allen Institute High-Impact Data Challenge (Seattle, WA)
FoundedNot publicly disclosed (published company research updates date to at least October 2024)
Founders / LeadershipAsim Iqbal (Founder & CEO)
StageAccelerator (NIH SBIR Grant-Backed)
Announced Funding$400,000 non-dilutive NIH SBIR grant (August 2026); no institutional VC round publicly disclosed
Team SizeNot publicly disclosed
Primary Ecosystem TiesPlug and Play Seattle (Batch 3, Mar-Jun 2026); Allen Institute; NVIDIA Inception Program (May 2026)

Washington Footprint and Leadership

Public records place Tibbling Technologies in the Greater Seattle area with a transparent city-level nuance across primary sources: federal National Institutes of Health SBIR grant records and scientific affiliations list Redmond, Washington on the Eastside, while Plug and Play Seattle's Batch 3 announcement listed the startup as based in Seattle. During the 12-week spring 2026 Plug and Play program, cohort founders had access to Plug and Play's Seattle office inside UW's CoMotion Labs and space at SNBL Global Gateway in Everett, showcasing at UW's Kane Hall on June 5, 2026. The company's site also records participation with Seattle's Allen Institute for its High-Impact Data Challenge in August 2025.

Tibbling Technologies is led by Founder & CEO Asim Iqbal, a NeuroAI and computational neuroscience researcher focused on brain-inspired computing and deep learning architectures. Company updates on tibbtech.com highlight collaborations with researchers at institutions including Burke Neurological Institute (BNI) and Weill Cornell Medicine, alongside earlier work co-authored with researchers from Harvard Medical School and the Broad Institute, and co-organizing a NeuroAI workshop at AAAI in Singapore in January 2026. Readers locating the firm online should note that tibbtech.com (resolving to www.tibbtech.com) is the active official website, whereas tibbling.com displays only a minimal 12-byte placeholder.

Seattle waterfront startup incubator loft overlooking Puget Sound ferry lanes and the Olympic Mountains
Washington AI ecosystem context: Seattle waterfront startup incubator loft overlooking Puget Sound ferry lanes and the Olympic Mountains.

Products, Users, and Public Traction

Tibbling Technologies serves life sciences researchers, neuroscience laboratories, healthcare organizations, and medical imaging teams rather than mass-market software buyers. Its public track record on tibbtech.com emphasizes peer-reviewed publications, scientific preprints, and research collaborations rather than off-the-shelf SaaS pricing or commercial seat metrics.

Notable verified milestones include its August 2026 $400,000 NIH SBIR grant award, acceptance into the NVIDIA Inception Program in May 2026, participation in the Allen Institute High-Impact Data Challenge in August 2025, and a July 2026 research update describing how its AI platform assisted researchers at Burke Neurological Institute and Weill Cornell Medicine in identifying a brainstem-targeting motor circuit relevant to stroke and spinal cord injury recovery. Named commercial enterprise customers, revenue figures, founding year, and team headcount are not publicly disclosed.

Funding, Stage, and Place in Washington's AI Landscape

Tibbling Technologies is an accelerator- and grant-backed startup. Its verified funding consists of a $400,000 non-dilutive NIH SBIR grant reported in August 2026, alongside acceptance into Plug and Play Seattle Batch 3 (March to June 2026) and Plug and Play Tech Center's startup network. No institutional venture capital equity round or acquisition has been publicly announced through November 2026.

Within Washington's life-sciences and health-AI cluster, Tibbling Technologies stands out for grounding its multimodal models in computational neuroscience and neuromorphic efficiency—bridging Puget Sound's research anchor at the Allen Institute and UW corridor with Eastside Redmond operations. It operates alongside Seattle-area peers applying AI to physiological foundation models, live-cell imaging, and autonomous drug discovery.

Related Washington AI Profiles & Tygart Media Context

Verified Primary Sources

Get The Signal

What we actually ran, what it measured, and what it means for a restoration shop — every week, including the flops.

Subscription Form

Track the AI tools you actually use
Vendor-neutral prices & limits for ChatGPT, Claude, Gemini, Perplexity and more — tracked in AI Stack Watch.
See the live AI tracker →or set up your alerts

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *